(Q36738741)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

title

Effect of verapamil on systemic exposure and safety of umeclidinium and vilanterol: a randomized and open-label study (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

ChEBI release 2020-05-28

1 reference

ChEBI release 2020-05-28

1 reference

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Glenn Crater

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

author name string

Rashmi Mehta

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Dennis Kelleher

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

Stephen Hughes

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

language of work or name

English

0 references

publication date

27 March 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

International Journal of Chronic Obstructive Pulmonary Disease

28 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

volume

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

page(s)

159-167

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

Creative Commons Attribution-NonCommercial 3.0 Unported

28 February 2020

copyright license

start time

1 March 2013

1 reference

April 2022 Public Data File from Crossref

copyright status

copyrighted

0 references

cites work

Safety, tolerability, pharmacodynamics and pharmacokinetics of umeclidinium and vilanterol alone and in combination: a randomized crossover trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

COPD uncovered: an international survey on the impact of chronic obstructive pulmonary disease [COPD] on a working age population

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

β(2) -adrenoceptor agonists: current and future direction

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Long-acting beta-agonists in the management of chronic obstructive pulmonary disease: current and future agents

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

A review of the GOLD guidelines for the diagnosis and treatment of patients with COPD.

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

The epidemiology and economics of chronic obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Assessment of the economic burden of COPD in the U.S.: a review and synthesis of the literature

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Global burden of COPD: systematic review and meta-analysis

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

A benefit-risk assessment of inhaled long-acting beta2-agonists in the management of obstructive pulmonary disease

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Cardiovascular safety of beta(2)-adrenoceptor agonist use in patients with obstructive airway disease: a systematic review

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Synthesis and structure-activity relationships of long-acting beta2 adrenergic receptor agonists incorporating metabolic inactivation: an antedrug approach

29 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

The 2010 NICE COPD Guidelines: how do they compare with the GOLD guidelines?

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Co-morbid association of depression and COPD: a population-based study.

5 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3615930

Vilanterol trifenatate, a novel inhaled long-acting beta2 adrenoceptor agonist, is well tolerated in healthy subjects and demonstrates prolonged bronchodilation in subjects with asthma and COPD

5 September 2018

1 reference

12 December 2020

A randomized, double-blind dose-ranging study of the novel LAMA GSK573719 in patients with COPD

1 reference

12 December 2020

28-Day safety and tolerability of umeclidinium in combination with vilanterol in COPD: a randomized placebo-controlled trial

1 reference

12 December 2020

Bronchodilation of umeclidinium, a new long-acting muscarinic antagonist, in COPD patients

1 reference

12 December 2020

Identifiers

DOI

10.2147/COPD.S40859

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23569370%20AND%20SRC:MED&resulttype=core&format=json

28 February 2020

1 reference